€8.39
1.41% today
Frankfurt, Aug 12, 08:02 am CET
ISIN
SE0017769995
Symbol
BGLA

BioGaia Stock price

€8.51
-1.05 10.94% 1M
-2.28 21.13% 6M
-0.68 7.40% YTD
-1.98 18.84% 1Y
+0.57 7.17% 3Y
-0.98 10.33% 5Y
+3.89 84.13% 10Y
+8.28 3,609.68% 20Y
Frankfurt, Closing price Mon, Aug 11 2025
+0.08 0.89%
ISIN
SE0017769995
Symbol
BGLA
Industry

Key metrics

Basic
Market capitalization
€862.2m
Enterprise Value
€806.6m
Net debt
positive
Cash
€55.6m
Shares outstanding
101.2m
Valuation (TTM | estimate)
P/E
34.0 | 23.9
P/S
6.7 | 6.3
EV/Sales
6.3 | 5.9
EV/FCF
29.1
P/B
8.4
Dividends
DPS
€0.63
Yield 1Y | 5Y
2.1% | 1.4%
Growth 1Y | 5Y
15.7% | 23.5%
Payout 1Y | 3Y
203.9% | 148.9%
Increased
4 Years
Financials (TTM | estimate)
Revenue
€128.6m | €137.1m
EBITDA
€33.6m | €45.0m
EBIT
€31.3m | €42.3m
Net Income
€25.6m | €36.0m
Free Cash Flow
€27.7m
Growth (TTM | estimate)
Revenue
5.1% | 7.9%
EBITDA
-25.2% | 21.1%
EBIT
-26.8% | 15.6%
Net Income
-28.7% | 14.6%
Free Cash Flow
-14.0%
Margin (TTM | estimate)
Gross
72.5%
EBITDA
26.1% | 32.8%
EBIT
24.3%
Net
19.9% | 26.2%
Free Cash Flow
21.5%
Financial Health
Equity Ratio
84.8%
Return on Equity
20.4%
ROCE
28.0%
ROIC
-
Debt/Equity
0.0
More
EPS
€0.3
FCF per Share
€0.3
Short interest
-
Employees
225
Rev per Employee
€560.0k
Show more

Is BioGaia a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

BioGaia Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a BioGaia forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a BioGaia forecast:

Buy
83%
Hold
17%

Financial data from BioGaia

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
129 129
5% 5%
100%
- Direct Costs 35 35
11% 11%
28%
93 93
3% 3%
72%
- Selling and Administrative Expenses 46 46
19% 19%
36%
- Research and Development Expense 14 14
56% 56%
11%
34 34
25% 25%
26%
- Depreciation and Amortization 2.33 2.33
8% 8%
2%
EBIT (Operating Income) EBIT 31 31
27% 27%
24%
Net Profit 26 26
29% 29%
20%

In millions EUR.

Don't miss a Thing! We will send you all news about BioGaia directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Theresa Agnew
Employees 225
Founded 1990
Website sv.biogaia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today